
Reset all filters
01 2Grifols International
02 2Pfizer Inc
03 2Rigel Pharmaceuticals
Reset all filters
01 2Film Coated Tablet
02 2Solution For Injection
03 2TABLET;ORAL
Reset all filters
01 2Approved
02 2Authorized
03 2RX
Reset all filters
01 2Hympavzi
02 2TAVALISSE
03 2Tavlesse
Reset all filters
01 2Spain
02 2Sweden
03 2USA
Regulatory Info : Authorized
Registration Country : Spain
Fostamatinib Disodium Hexahydrate
Brand Name : Tavlesse
Dosage Form : Film Coated Tablet
Dosage Strength : 100MG
Packaging :
Approval Date : 2020-06-03
Application Number : 1191405001
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Authorized
Registration Country : Spain
Fostamatinib Disodium Hexahydrate
Brand Name : Tavlesse
Dosage Form : Film Coated Tablet
Dosage Strength : 150MG
Packaging :
Approval Date : 2020-06-03
Application Number : 1191405002
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Hympavzi
Dosage Form : Solution For Injection
Dosage Strength : 150mg
Packaging :
Approval Date : 18/11/2024
Application Number : 20231009000225
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Hympavzi
Dosage Form : Solution For Injection
Dosage Strength : 150mg
Packaging :
Approval Date : 18/11/2024
Application Number : 20231009000218
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : RX
Registration Country : USA
Brand Name : TAVALISSE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 2018-04-17
Application Number : 209299
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : TAVALISSE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 150MG BASE
Packaging :
Approval Date : 2018-04-17
Application Number : 209299
Regulatory Info : RX
Registration Country : USA